MBF Therapeutics
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
640 Woodbrook Dr, Ambler, Pennsylvania, ...Phone Number
(215) 620-3699Website
www.mbftherapeutics.comRevenue
<$5 MillionIndustry
About MBF Therapeutics
MBF Therapeutics is an immunotherapeutic animal health company that utilizes its innovative T-Max DNA vaccine platform to develop groundbreaking products aimed at combating infectious diseases and cancer in animals. The company is focused on creating highly effective, universal vaccines that not only address current and emerging infectious diseases in animals but also have potential applications in human health. MBF Therapeutics is committed to the One World, One Health concept, recognizing the interconnectedness of animal and human health, and seeks partnerships with major vaccine companies to further its mission. Through its T-Max platform, the company aims to generate proof of concept clinical data that will facilitate the development of specific opportunities in human health.Explore more
SIC Code 87,873NAICS Code 54,541Show moreMBF Therapeutics Org Chart
Compare Similar Companies to MBF Therapeutics
Compare insights from companies similar to MBF Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MBF Therapeutics Tech Stack
A closer look at the technologies used by MBF Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MBF Therapeutics
Sign Up For FreeTo access detailed company insights
MBF Therapeutics is an immunotherapeutic animal health company that utilizes its innovative T-Max DNA vaccine platform to develop groundbreaking products aimed at combating infectious diseases and cancer in animals. The company is focused on creating highly effective, universal vaccines that not only address current and emerging infectious diseases... Read More